AI Article Synopsis

  • Patients with thin endometrium often face difficulties with pregnancy during frozen-thawed embryo transfers; enhancing endometrial receptivity may help.
  • A study involving 150 patients tested the effects of intrauterine perfusion of granulocyte colony-stimulating factor (G-CSF) and human chorionic gonadotropin (HCG) on pregnancy outcomes, comparing results among three groups (control, HCG, and G-CSF).
  • The G-CSF group showed significant improvements in endometrial thickness, blood flow, and Treg levels, resulting in higher pregnancy rates than both the HCG and control groups, indicating G-CSF's potential benefit for patients with thin endometrium.

Article Abstract

Background: Patients with thin endometrium undergoing frozen-thawed embryo transfer often encounter challenges with pregnancy outcomes. Enhancing endometrial receptivity and immune tolerance may improve these outcomes.

Objective: To investigate the effects of intrauterine perfusion of granulocyte colony-stimulating factor (G-CSF) and human chorionic gonadotropin (HCG) on regulatory T cells (Tregs) and pregnancy outcomes in patients with thin endometrium undergoing frozen-thawed embryo transfer.

Methods: 150 patients with thin endometrium were randomly assigned to three groups: a control group that received no intervention, an HCG group, and a G-CSF group. The effectiveness of the treatments was assessed by comparing uterine parameters, Treg levels, and pregnancy outcomes across the groups.

Results: The HCG and G-CSF groups exhibited significant improvements compared to the control group, including increased endometrial thickness, enhanced blood flow, higher expression of endometrial receptivity markers (integrin αvβ3, osteopontin), and elevated Treg levels. Notably, the G-CSF group demonstrated even greater enhancements compared to the HCG group, with significantly higher endometrial thickness, better blood flow, increased receptivity markers, and elevated Treg levels. Additionally, the G-CSF group achieved significantly higher biochemical and clinical pregnancy rates compared to both the HCG and control groups. This highlights the potential of G-CSF in improving pregnancy outcomes for patients with a thin endometrium.

Conclusion: The intrauterine perfusion of G-CSF significantly enhanced pregnancy outcomes in patients with thin endometrium by improving endometrial blood flow, immune tolerance, thickness, Treg induction, and embryo implantation. These findings suggest that G-CSF could be a promising therapeutic option for this patient population.

Download full-text PDF

Source
http://dx.doi.org/10.22034/iji.2024.103095.2815DOI Listing

Publication Analysis

Top Keywords

patients thin
24
thin endometrium
20
pregnancy outcomes
20
endometrium undergoing
12
undergoing frozen-thawed
12
frozen-thawed embryo
12
outcomes patients
12
g-csf group
12
treg levels
12
blood flow
12

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!